Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Sensitive skin, Skin discolouration, Vaccination site erythema, Vaccination site oedema, Vaccination site pain
Clinical narrative: Fingers have turned bright red; Fatigue; Nausea; Migraine headache; Felt icky; Fingers swollen; Toes swollen; Red, tight, blue, purple dots on fingers; Red, tight, blue, purple dots on toes; Toes sensitive to touch; Fingers sensitive to touch; Felt itchy at site of injection; Pain at site of injection; Bright red at site of injection; Discomfort in temperature; Inflammation in toes; Raised area at site of injection; Hands became bluish in color; Unable to stand; Feet became cold; Hands became cold; Feet became bluish in color; This spontaneous case was reported by a consumer and describes the occurrence of DYSSTASIA (Unable to stand), PERIPHERAL COLDNESS (Feet became cold), PERIPHERAL COLDNESS (Hands became cold), SKIN DISCOLOURATION (Feet became bluish in color) and DISCOMFORT (Discomfort in temperature) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported by the reporter.  Concomitant products included METFORMIN, PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE], VITAMIN D NOS, MAGNESIUM, VITAMIN E NOS (VITAMIN E + MAGNESIUM), PROBIOTICS NOS, BIOTIN, PRAVASTATIN, HYDROCODONE and FAMOTIDINE (PEPCID AC) for an unknown indication.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced DYSSTASIA (Unable to stand), PERIPHERAL COLDNESS (Feet became cold), PERIPHERAL COLDNESS (Hands became cold), SKIN DISCOLOURATION (Feet became bluish in color) and SKIN DISCOLOURATION (Hands became bluish in color). On 15-Feb-2021, the patient experienced DISCOMFORT (Discomfort in temperature), INFLAMMATION (Inflammation in toes), VACCINATION SITE OEDEMA (Raised area at site of injection), VACCINATION SITE PRURITUS (Felt itchy at site of injection), VACCINATION SITE PAIN (Pain at site of injection) and VACCINATION SITE ERYTHEMA (Bright red at site of injection). On 16-Feb-2021, the patient experienced PERIPHERAL SWELLING (Fingers swollen), PERIPHERAL SWELLING (Toes swollen), SKIN DISCOLOURATION (Red, tight, blue, purple dots on fingers), SKIN DISCOLOURATION (Red, tight, blue, purple dots on toes), SENSITIVE SKIN (Toes sensitive to touch) and SENSITIVE SKIN (Fingers sensitive to touch). On 19-Feb-2021, the patient experienced MIGRAINE (Migraine headache), PRURITUS (Felt icky), FATIGUE (Fatigue) and NAUSEA (Nausea). On 01-Mar-2021, the patient experienced ERYTHEMA (Fingers have turned bright red). At the time of the report, DYSSTASIA (Unable to stand), PERIPHERAL COLDNESS (Feet became cold), PERIPHERAL COLDNESS (Hands became cold), SKIN DISCOLOURATION (Feet became bluish in color), DISCOMFORT (Discomfort in temperature), SKIN DISCOLOURATION (Hands became bluish in color), VACCINATION SITE OEDEMA (Raised area at site of injection), PERIPHERAL SWELLING (Fingers swollen), PERIPHERAL SWELLING (Toes swollen), SKIN DISCOLOURATION (Red, tight, blue, purple dots on fingers), SKIN DISCOLOURATION (Red, tight, blue, purple dots on toes), SENSITIVE SKIN (Toes sensitive to touch), SENSITIVE SKIN (Fingers sensitive to touch), MIGRAINE (Migraine headache), PRURITUS (Felt icky), FATIGUE (Fatigue), NAUSEA (Nausea), VACCINATION SITE PRURITUS (Felt itchy at site of injection), VACCINATION SITE PAIN (Pain at site of injection) and VACCINATION SITE ERYTHEMA (Bright red at site of injection) had not resolved, INFLAMMATION (Inflammation in toes) was resolving and ERYTHEMA (Fingers have turned bright red) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: This Follow-up was received on 07-MAY-2021 which updated event outcome as not recovered/not resolved.